FindTrial
Sign In

USE OF DEXMEDITOMIDINE TO REDUCE HEART RATE AND B.P IN ELECTRIC SHOCK THERAPY IN PSYCHIATRIC PATIENTS

TO STUDY EFFECT OF DEXMEDETOMIDINE IN ATTENUATION OF HYPERDYNAMIC PRESSOR RESPONSE IN ELECTRO CONVULSIVE THERAPY - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/12/060406
Enrollment
60
Registered
2023-12-01
Start date
Unknown
Completion date
Unknown
Last updated
2023-12-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: F063- Mood disorder due to known physiological condition

Interventions

Intervention1: DEXMEDETOMIDINE IN DOSE OF 0.5MCG/KG: DEXMEDETOMIDINE IN DOSE OF 0.5MCG/KG TO ALL PATIENTS POSTED FOR ECT Control Intervention1: NORMAL SALINE: 100 ML OF NORMAL SALINE TO ALL PATIENTS P

Sponsors

SIMRAN NATHANI
Lead Sponsor
DR NEHA PANSE
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: PATIENTS SCHEDULED FOR ECT ALL PATIENTS UNDER ASA I AMD II

Exclusion criteria

Exclusion criteria: CARDIOVASCULAR DISEASE PT ON BETA BLOCKERS PRE EXISITING BRADYCARDIA NON CONSENT TO PARTICIPATE IN STUDY

Design outcomes

Primary

MeasureTime frame
DEXMEDETOMIDINE IS EFFECTIVE IN ATTENUATION OF HYPERDYNAMIC PRESSOR RESPONSE IN ECTTimepoint: BEFORE GIVING DRUG 2 MINS AFTER GIVING DRUG BEFORE SHOCK AFTER SHOCK AT TIME OF SHIFTING TO RECOVERY—

Secondary

MeasureTime frame
SEDATION SCORE DURATION OF SEIZURES AFTER SHOCKTimepoint: BEFORE GIVING DRUG 2 MINS AFTER GIVING DRUG BEFORE SHOCK AFTER SHOCK AT TIME OF SHIFTING TO RECOVERY—

Countries

India

Contacts

Public ContactSIMRAN NATHANI

Maharashtra university of health sciences.

drnehaghule@gmail.com9689495891

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026